We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 15,828

Dietary Supplement Legal Update - September 2016
  • Porzio Bromberg & Newman PC
  • USA
  • September 22 2016

The dietary supplement industry continues to confront legal and regulatory challenges. Some recent significant developments are summarized below


Prop. 65 Conference Focuses on Compliance With New Warning and Settlement Regulations
  • Bryan Cave LLP
  • USA
  • September 22 2016

The Prop. 65 Clearinghouse held its annual conference in San Francisco recently, and the speakers and panelists had a number of recommendations for


Co-sleeping Safely: A Guide to Current Regulations of Infant Bedside Sleepers
  • Stinson Leonard Street LLP
  • USA
  • September 22 2016

The bedside sleeper, also sometimes called a "co-sleeper" or "co-sleeping bassinet," provides a baby and parent their own individual sleeping


New Jersey Court Rules Talcum Powder Claims Not Supported by Science
  • K&L Gates
  • USA
  • September 22 2016

Talcum powder has been widely used as a cosmetic and bath product by Americans for well over a century. In recent years, claims have been asserted


Is your cybersecurity upgrade FDA reportable?
  • DLA Piper LLP
  • USA
  • September 22 2016

In today’s marketplace, technology evolves at a rapid rate, and must adapt to changing circumstances, such as threats to cybersecurity. For device


GMO Food Labeling And CRISPR
  • Foley & Lardner LLP
  • USA
  • September 22 2016

A new law targeted at GMO food labeling instructs the Secretary of Agriculture to establish standards for identifying “bioengineered” food. While


Safely Handle the "Safety Rule" Question
  • Holland & Hart LLP
  • USA
  • September 22 2016

Don't you think that, when faced with a choice between a safer option and a riskier option, one should take the safer option? Well, on face that seems


Administration’s Biotechnology Working Group Updates Coordinated Framework & Unveils National Strategy
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • September 21 2016

After launching with an ambitious agenda fourteen months ago (as we wrote about here), last Friday the Obama Administration announced that its


Florida Tightens the Reins on Proving Causation in Asbestos Claims
  • Wilson Elser
  • USA
  • September 21 2016

On September 14, 2016, Florida joined a growing number of jurisdictions that reject the “any exposure” theory of proving causation. Variously known as


Aralez’s YOSPRALA wins FDA approval
  • Knobbe Martens Olson & Bear LLP
  • USA
  • September 21 2016

On September 15, 2016, the U.S. Food and Drug Administration approved once-daily YOSPRALA, a tablet that combines the anti-platelet agent, aspirin